michigan glp-1 diarrhea legal team Medicare Bridge Program As GLP-1 weight loss medications

Effectiveness A 2023 JAMA Network study found that participants using tirzepatide lost an average of 25% of body fat within the first yearcompared to about 15% for semaglutide users

The Precision Peptide Genetic Test examines predispositions in key peptide pathway genes (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) to help your provider understand your metabolic trajectory

For type 2 diabetes, GLP-1 medications are typically long-term treatments due to the progressive nature of the condition, though some patients may reduce therapy with sustained lifestyle changes

Four participants did not complete the study: three due to complications from chronic medical conditions and one due to fatigue